Video Experimental Relacionado
Updated: Jul 9, 2026
06:34
A Component-resolved Diagnostic Approach for a Study on Grass Pollen Allergens in Chinese Southerners with Allergic Rhinitis and/or Asthma
Published on: June 4, 2017
La prostaglandina D2 como mediador del asma alérgica
T Matsuoka1, M Hirata, H Tanaka
1Department of Pharmacology, Kyoto University Faculty of Medicine, Kyoto 606-8501, Japan.
Science (New York, N.Y.)
|March 17, 2000
Resumen
La prostaglandina D2 (PGD2) juega un papel clave en el asma alérgica mediante la activación de los mastocitos. Los ratones que carecían del receptor PGD2 (DP) mostraron una reducción de los síntomas de asma, lo que indica que PGD2 es crucial para desencadenar la inflamación alérgica de las vías respiratorias.
Área de la Ciencia:
- Inmunología Inmunología.
- Investigación de Alergias Investigación de Alergias
- Medicina de las vías respiratorias Medicina de las vías respiratorias
Sus antecedentes:
- El asma alérgica involucra a las células productoras de citoquinas T ayudante tipo 2 (TH2), la infiltración de eosinófilos y la hiperreactividad bronquial.
- Los mastocitos, activados por la inmunoglobulina E (IgE), liberan mediadores como la prostaglandina D2 (PGD2) durante las reacciones alérgicas.
Objetivo del estudio:
- Para investigar el papel de la prostaglandina D2 (PGD2) en el asma alérgica.
- Para determinar si la señalización de PGD2 a través de su receptor (DP) es esencial para el desarrollo del asma.
Principales métodos:
- Generación de ratones con deficiencia en el receptor PGD2 (ratones DP-/-).
- Inducción del asma alérgica utilizando la sensibilización con ovalbumina (OVA) y el desafío del aerosol en ratones DP-/- y de tipo salvaje.
- Evaluación de los niveles séricos de IgE, las concentraciones de citoquinas TH2, la acumulación de linfocitos, la infiltración de eosinófilos y la hiperreactividad de las vías respiratorias.
Principales resultados:
- Los ratones DP-/- exhibieron aumentos de IgE similares a los ratones de tipo salvaje después del desafío OVA.
- Los ratones DP-/- desafiados por OVA mostraron niveles significativamente reducidos de citoquinas TH2 y acumulación de linfocitos en los pulmones.
- Los ratones DP-/- mostraron una mínima infiltración de eosinófilos y carecían de hiperreactividad de las vías respiratorias en comparación con los controles.
Conclusiones:
- La prostaglandina D2 (PGD2) actúa como un mediador derivado de mastocitos crítico para desencadenar respuestas alérgicas de asma.
- La inhibición de la señalización de PGD2 a través de su receptor (DP) puede mejorar las principales patologías del asma, incluida la inflamación y la hiperreactividad.
Videos de Conceptos Relacionados
01:30Antihypertensive Drugs: Angiotensin II Receptor Blockers
In the renin-angiotensin-aldosterone system, a hormone called angiotensin II plays a crucial role. It binds to the AT1 receptors in vascular smooth muscles coupled with Gq proteins. The activation of these receptors activates an enzyme called phospholipase C, which releases two molecules: inositol trisphosphate and diacylglycerol. These molecules cause a chain reaction that leads to the phosphorylation of myosin light chains and promotes interaction between actin and myosin, leading to smooth...
01:17Drugs Used in Lower Respiratory Disorders: Overview
Lower respiratory tract disorders present challenges that often require skilled and nuanced approaches for effective management. Common ailments, such as asthma and chronic obstructive pulmonary disease (COPD), have prompted the development of intricate treatment strategies involving bronchodilators and anti-inflammatory drugs, each tailored to ease breathing and revitalize the lungs.
Bronchodilators, the first step of respiration enhancement, come in various forms, each with its own mechanism...
Bronchodilators, the first step of respiration enhancement, come in various forms, each with its own mechanism...
01:19Antiasthma Drugs: Leukotriene Modifiers
Leukotriene modifiers, or cysteinyl leukotriene receptor antagonists, are medications used to manage chronic asthma. These agents target specific inflammatory mediators produced during arachidonic acid metabolism, an essential process in generating inflammation in the body.
Leukotriene modifiers work through two distinct mechanisms:
Leukotriene modifiers work through two distinct mechanisms:
01:25Antiasthma Drugs: Mast Cell Stabilizers and Anti-IgE Drugs
Asthma is a chronic respiratory condition for which new therapeutic avenues, including anti-inflammatory drugs like mast cell stabilizers and anti-IgE treatments, continue to be developed.
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
01:26Asthma-II: Pathophysiology and Classification
Asthma is a prevalent chronic respiratory condition marked by inflammation and hyperresponsiveness of the airways. Its pathophysiology involves complex interactions among inflammatory pathways, immune responses, and neural mechanisms.
Additionally, environmental and genetic factors play crucial roles in determining an individual's susceptibility to asthma and the severity of their condition.
Critical processes in asthma pathophysiology include:
Additionally, environmental and genetic factors play crucial roles in determining an individual's susceptibility to asthma and the severity of their condition.
Critical processes in asthma pathophysiology include:
01:20Inflammatory Bowel Disease II: Ulcerative Colitis
Ulcerative colitis is a chronic inflammatory disorder of the colon characterized by continuous mucosal inflammation that typically begins in the rectum and extends proximally in a uniform pattern. Its pathogenesis involves a complex interplay of genetic predisposition, immune dysregulation, and environmental influences. These factors converge to impair the colon’s epithelial defenses and promote an exaggerated inflammatory response against luminal contents.Breakdown of the Mucosal BarrierA...